AsialoGM1 and integrin α2β1 mediate prostate cancer progression

International Journal of Oncology

Volumn 35, Issue 4, 2009, Pages 693-699

  Van Slambrouck, Severine ^a   Hilkens, John ^b   Bisoffi, Marco ^c   Steelant, Wim F A ^a  

^a NEW MEXICO INSTITUTE OF MINING AND TECHNOLOGY   (United States)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Adhesion; Extracellular matrix; Glycosphingolipid; Invasion; Migration; Prostate cancer

Indexed keywords

GANGLIOTETRAOSYLCERAMIDE; GLYCOSPHINGOLIPID; VERY LATE ACTIVATION ANTIGEN 2; GANGLIOSIDE GM1;

ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INVASION; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL SURFACE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; BONE TUMOR; CELL MEMBRANE; CELL MOTION; DISEASE COURSE; METABOLISM; PATHOLOGY; PROSTATE TUMOR; PROTEIN BINDING; TUMOR CELL LINE;

BONE NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL MEMBRANE; CELL MOVEMENT; DISEASE PROGRESSION; G(M1) GANGLIOSIDE; HUMANS; INTEGRIN ALPHA2BETA1; MALE; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; PROTEIN BINDING; SIGNAL TRANSDUCTION;

EID: 70449413146     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000381     Document Type: Article

References (26)

1. Hakomori SI: Structure and function of glycosphingolipids and sphingolipids: recollections and future trends. Biochim Biophys Acta 1780: 325-346, 2008.
2. Hakomori S: Tumor malignancy defined by aberrant glycosylation and sphingo(glycol)lipid metabolism. Cancer Res 56: 5309-5318, 1996.
3. Ruggieri S, Mugnai G, Mannini A, Calorini L, Fallani A, Barletta E, Mannori G and Cecconi O: Lipid characteristics in metastatic cells. Clin Exp Metastases 17: 271-276, 1999.
4. Furukawa K, Hamamura K, Nakashima H and Furukawa K: Molecules in the signaling pathway activated by gangliosides can be targets of therapeutics for malignant melanomas. Proteomics 8: 3312-3316, 2008.
5. Von Holst H, Nygren C, Boström K, Collins VP and Fredman P: The presence of foetal ganglioside antigens 3′-isoLLM1 and 3′6′-isoLD1 in both glioma tissue and surrounding areas of the human brain. Acta Neurochir 139: 141-145, 1997. (Pubitemid 27096306)
6. Hoon DS, Okun E, Neuwirth H, Morton DL and Irie RF: Aberrant expression of gangliosides in human renal cell carcinomas. J Urol 150: 2013-2018, 1993. (Pubitemid 24350855)
7. Ohkawa Y, Miyazaki S, Miyata M, Hamamura K, Furukawa K and Furukawa K: Essential roles of integrin-mediated signaling for the enhancement of malignant properties of melanomas based on the expression of GD3. Biochem Biophys Res Commun 373: 14-19, 2008.
8. Van Slambrouck S, Jenkins AR, Romero AE and Steelant WFA: Reorganization of the integrin α2 subunit controls cell adhesion and cancer cell invasion in prostate cancer. Int J Oncol 34: 1717-1726, 2009.
9. Toledo MS, Suzuki E, Handa K and Hakomori S: Effect of ganglioside and tetraspanins in microdomains on interaction of integrins with fibroblast growth factor receptor. J Biol Chem 280: 16227-16234, 2005. (Pubitemid 40616749)
10. Todeschini AR, Dos Santos JN, Handa K and Hakomori S: Ganglioside GM2-tetraspanin CD82 complex inhibits met and its cross-talk integrins providing a basis for control of cell motility through glycosynapse. J Biol Chem 282: 8123-8133, 2007. (Pubitemid 47093583)
11. Thalmann GN, Sikes RA, Wu TT, Degeorges A, Chang SM, Ozen M, Pathak S and Chung LW: LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis. Prostate 44: 91-103, 2000. (Pubitemid 30419183)
12. Sigstedt SC, Hooten CJ, Callewaert MC, Jenkins AR, Romero AE, Pullin MJ, Kornienko A, Lowrey TK, van Slambrouck S and Steelant WF: Evaluation of aqueous extracts of Taraxacum officinale on growth and invasion of breast and prostate cancer cells. Int J Oncol 32: 1085-1090, 2008.
13. Geho DH, Bandle RW, Clair T and Liotta LA: Physiological mechanisms of tumor-cell invasion and migration. Physiology 20: 194-200, 2005. (Pubitemid 40807057)
14. Moore ML, Chi MH, Goleniewska K, Durbin JE and Peebles RS Jr: Differential regulation of GM1 and asialo-GM1 expression by T cells and natural killer (NK) cells in respiratory syncytial virus infection. Viral Immunol 21: 327-339, 2008.
15. Dasgupta S, van Halbeek H and Hogan EL: Ganglio-N-tetraosylceramide (GA1) of bovine and human brain. Molecular characterization and presence in myelin. FEBS Lett 301: 141-144, 1992.
16. Saiman L and Prince A: Pseudomonas aeruginosa pili bind to AsialoGM1 which is increased on the surface of cystic fibrosis epithelial cells. J Clin Invest 92: 1875-1880, 1993.
17. Krivan HC, Ginsburg V and Roberts DD: Pseudomonas aeruginosa and Pseudomonas cepacia isolated from cystic fibrosis patients bind specifically to gangliotetraosylceramide (AsialoGM1) and gangliotriaosylceramide (AsialoGM2). Arc Biochem Biophys 260: 493-496, 1988.
18. De Bentzmann S, Roger P, Dupuit F, Bajolet-Laudinat O, Fuchey C, Plotkowski MC and Puchelle E: Asialo GM1 is a receptor for Pseudomonas aeruginosa adherence to regenerating respiratory epithelial cells. Infect Immun 64: 1582-1588, 1996.
19. Enzan H, Hiroi M, Saibara T, Onishi S, Yamamoto Y, Yamamoto H and Hara H: Immunoelectron microscopic identification of asialoGM1-positive cells in adult rat liver. Virchows Arc B Cell Pathol 60: 389-398, 1991.
20. McNamara N and Basbaum C: Signaling networks controlling mucin production in response to Gram-positive and Gram-negative bacteria. Glycoconj J 18: 715-722, 2001. (Pubitemid 35402108)
21. Wang JC, Bégin LR, Bérubé NG, Chevalier S, Aprikian AG, Gourdeau H and Chevrette M: Down-regulation of CD9 expression during prostate carcinoma progression is associated with CD9 mRNA modifications. Clin Cancer Res 13: 2354-2361, 2007. (Pubitemid 46698584)
22. Dong JT, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT and Barrett JC: KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 268: 884-886, 1995.
23. Lazo PA: Functional implications of tetraspanin proteins in cancer biology. Cancer Sci 98: 1666-1677, 2007. (Pubitemid 47487899)
24. Tettamanti G: Ganglioside/glycosphingolipid turnover: new concepts. Glycoconj J 20: 301-317, 2004.
25. Miyagi T, Wada T, Yamaguchi K and Hata K: Sialidase and malignancy: a minireview. Glycoconj J 20: 189-198, 2004.
26. Miyagi T: Aberrant expression of sialidase and cancer progression. Proc Jpn Acad Ser B Phys Biol Sci 84: 407-418, 2008.